| Date | Description | Link | |
|---|---|---|---|
|
2024 |
Interim and Year-end Reports to Shareholders |
|
|
|
Q3-2024 |
MD & A for the three and nine months ended September 30, 2024 Financial Statements for the three and nine months ended September 30, 2024 |
||
|
Q2-2024 |
MD & A for the three and six months ended June 30, 2024 Financial Statements for the three and six months ended June 30, 2024 |
||
|
Q1-2024 |
MD & A for the three months ended March 31, 2024 Financial Statements for the three months ended March 31, 2024 |
||
|
2023 |
Interim and Year-end Reports to Shareholders |
|
|
|
Q4-2023 |
MD & A for the year ended December 31, 2023 Financial Statements for the year ended December 31, 2023 Annual Information Form 2023 |
||
|
Q3-2023 |
MD &A for the three and nine month periods ended Sep 30, 2023 Financial statements for the three and nine month periods ended Sep 30, 2023 |
||
|
Q2-2023 |
MD &A for the three and six month periods ended June 30, 2023 Financial statements for the three and six month periods ended June 30, 2023 |
||
|
Q1-2023 |
MD &A for the three months ended March 31, 2023 Financial statements for the three months ended March 31, 2023 |
||
|
2022 |
Interim and Year-end Reports to Shareholders |
|
|
|
Q4-2022 |
MD & A for the year ended December 31, 2022 Financial Statements for the year ended December 31, 2022 Annual Information Form 2022 |
||
|
Q3-2022 |
MD & for the three and nine month periods ended September 30, 2022 Financial statements for the three and nine months ended September 30, 2022 |
||
|
Q2-2022 |
MD &A for the three and six month periods ended June 30, 2022 Financial statements for the three and six month periods ended June 30, 2022 |
||
|
Q1-2022 |
MD &A for the three and six month periods ended March 31, 2022 Financial statements for the three and six month periods ended March 31, 2022 |
||
|
2021 |
Interim and Year-end Reports to Shareholders |
||
|
Q4-2021 |
MD & A for the year ended December 31, 2021 Financial Statements for the year ended December 21, 2021 Annual Information Form 2021 Annual Report 2021 |
||
|
Q3-2021 |
MD & A for the three and nine months ended September 30, 2021 Financial statements for the three and nine months ended September 30, 2021 |
||
|
Q2-2021 |
MD & A for the three and six months ended June 30, 2021 Financial statements for the three and six months ended June 30, 2021 |
||
|
Q1-2021 |
MD & A for the 3-month period ended March 31, 2021 Financial Statements for the 3-month period ended March 31, 2021 Amended Consolidated Financial Statements for the years ended December 31, 2018, 2019, 2020 |
||
|
2020 |
Interim and Year-end Reports to Shareholders |
||
|
Q4-2020 |
MD & A for the year ended December 31, 2020 Financial Statements for the year ended December 31, 2020 Annual Information Form for the year ended December 31, 2020 Annual Report 2020 |
||
|
Q3-2020 |
MD & A for the 3-month period ended September 30, 2020 Financial Statements for the 6-month period ended September 30, 2020 |
||
|
Aug-2020 |
Report of Voting Results |
||
|
Q2-2020 |
MD & A for the 3-month period ended June 30, 2020 Financial Statements for the 6-month period ended June 30, 2020 |
||
|
Q1-2020 |
MD & A for the 3-month period ended March 31, 2020 Financial Statements for the 3-month period ended March 31, 2020 |
||
|
2019 |
Interim and Year-end Reports to Shareholders |
|
|
|
Q4-2019 |
MD & A for the year ended December 31, 2019 Financial Statements for the year ended December 31, 2019 Annual Information Form for the year ended December 31, 2019 Annual Report 2019 |
||
|
Q3-2019 |
MD & A for the 9-month period ended September 30, 2019 Financial Statements for the 9-month period ended Septemer 30, 2019 Report to Shareholders for the 9-month period ended Septemer 30, 2019 |
||
|
Q2-2019 |
MD & A for the 6-month period ended June 30, 2019 Financial Statements for the 6-month period ended June 30, 2019 |
||
|
Q1-2019 |
MD & A for the 3-month period ended March 31, 2019 Financial Statements for the 3-month period ended March 31, 2019 |
||
|
2018 |
Interim and Year-end Reports to Shareholders |
||
|
Q4-2018 |
Financial Statements for the fiscal year ended December 31, 2018 MD & A for the fiscal year ended December 31, 2018 Annual Information Form for the year ended December 31, 2018 Annual Report 2018 |
||
|
Q3-2018 |
MD & A for the 9-month period ended September 30, 2018 Financial Statements for the 9-month period ended September 30, 2018 |
||
|
Q2-2018 |
MD & A for the 6-month period ended June 30, 2018 Financial Statements for the 6-month period ended June 30, 2018 |
||
|
Q1-2018 |
MD & A for the 3-month period ended March 31, 2018 (Amended) Financial Statements for the 3-month period ended March 31, 2018 |
||
|
2017 |
Interim and Year-end Reports to Shareholders |
||
|
Q4-2017 |
MD & A and financial statements for the fiscal year ended December 31, 2017 Annual Information Form for the year ended December 31, 2017 |
||
|
Q3-2017 |
MD & A and financial statements for the 9-month period ended September 30, 2017 |
||
|
Q2-2017 |
MD & A and financial statements for the 6-month period ended June 30, 2017 |
||
|
Q1-2017 |
MD & A and financial statements for the 3-month period ended March 31, 2017 |
||
| Date | Description | Link |
|---|---|---|
|
2016 |
Interim and Year-end Reports to Shareholders |
|
|
Q4-2016 |
MD & A and financial statements for the fiscal year ended December 31, 2016 |
|
|
Q3-2016 |
MD & A and financial statements for the 9-month period ended September 30, 2016 |
|
|
Q2-2016 |
MD & A and financial statements for the 6-month period ended June 30, 2016 |
|
|
Q1-2016 |
MD&A and Financial Statements for the 3-month period ended March 31, 2016 |
|
|
2015 |
Interim and Year-end Reports to Shareholders |
|
|
Q4-2015 |
MD&A and Financial Statements for the fiscal year ended December 31, 2015 |
|
|
Q3-2015 |
MD&A and Financial Statements for the 9-month period ended September 30, 2015 |
|
|
Q2-2015 |
MD&A and Financial Statements for the 6-month period ended June 30, 2015 |
|
|
Q1-2015 |
MD&A and Financial Statements for the 3-month period ended March 31, 2015 |
|
|
2014 |
Interim and Year-end Reports to Shareholders |
|
|
Q4-2014 |
MD&A and Financial Statements for the fiscal year ended December 31, 2014 |
|
|
Q3 – 2014 |
MD&A and Financial Statements for the 9-month period ended September 30, 2014 |
|
|
Q2 – 2014 |
MD&A and Financial Statements for the 6-month period ended June 30, 2014 |
PDF |
|
Q1 – 2014 |
MD&A and Financial Statements for the 3-month period ended March 31, 2014 |
|
|
2013 |
Interim and Year-end Reports to Shareholders |
|
|
Q4 – 2013 |
MD&A and audited Financial Statements for the fiscal year ended December 31, 2013 |
|
|
Q3 – 2013 |
MD&A and Financial Statements for the 9-month period ended September 30, 2013 |
|
|
Q2 – 2013 |
MD&A and Financial Statements for the 6-month period ended June 30, 2013 |
|
|
Q1 – 2013 |
MD&A and Financial Statements for the 3-month period ended March 31, 2013 |
|
|
2012 |
Interim and Year-end Reports to Shareholders |
|
|
Q4 – 2012 |
MD&A and Financial Statements for the fiscal year ended December 31, 2012 |
|
|
Q3 – 2012 |
MD&A and Financial Statements for the 9-month period ended September 30, 2012 |
|
|
Q2 – 2012 |
MD&A and Financial Statements for the 6-month period ended June 30, 2012 |
|
|
Q1 – 2012 |
MD&A and Financial Statements for the 3-month period ended March 31, 2012 |
|
|
2011 |
|
|
|
Q4 – 2011 |
Audited Financial Statements for the fiscal year ended December 31, 2011 MD&A for the fiscal year ended December 31, 2011 |